LT1-3, a Slit2-Derived Peptide, Exhibits Anti-Tumor Activity and Improves Cisplatin Therapy

The Slit2/Robo signaling pathway acts as a tumor suppressor in various cancers. This study identified an 8-amino acid peptide, LT1-3, derived from the Slit2 LamG domain, and demonstrated its ability to inhibit lung cancer cell proliferation and invasion independently of Robo receptors. Notably, LT1-...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ting-Chien Wu, Chen-Yi Liao, Yu-Ying Lin, Shu-Ming Chuang, Szu-Yu Liu, Chi-Hsiang Wang, Shang-Er Su, Siang-Wei Wu, Ling-I Wang, Wei-Ting Chen, Sheng-Wen Cheng, Yu-Tang Huang, Yao-Bin Zheng, Cheng-Yen Chuang, Feng-Di Lung, Jinghua Tsai Chang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-10-01
Saila:	Cells
Gaiak:	LT1-3 Slit2 p53 <i>JNK1</i> Cisplatin APR246
Sarrera elektronikoa:	https://www.mdpi.com/2073-4409/14/21/1654
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!